PMC:7461420 / 39464-39572 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T215","span":{"begin":43,"end":47},"obj":"Disease"}],"attributes":[{"id":"A215","pred":"mondo_id","subj":"T215","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Compound 29 was only weakly active against SARS‐CoV‐1 Mpro (IC50, 800 µM) also in cellular antiviral assays."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T464","span":{"begin":28,"end":34},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Compound 29 was only weakly active against SARS‐CoV‐1 Mpro (IC50, 800 µM) also in cellular antiviral assays."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T384","span":{"begin":91,"end":100},"obj":"Chemical"}],"attributes":[{"id":"A384","pred":"chebi_id","subj":"T384","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"Compound 29 was only weakly active against SARS‐CoV‐1 Mpro (IC50, 800 µM) also in cellular antiviral assays."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1230","span":{"begin":54,"end":58},"obj":"Gene"},{"id":"1231","span":{"begin":43,"end":51},"obj":"Species"}],"attributes":[{"id":"A1230","pred":"tao:has_database_id","subj":"1230","obj":"Gene:8673700"},{"id":"A1231","pred":"tao:has_database_id","subj":"1231","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Compound 29 was only weakly active against SARS‐CoV‐1 Mpro (IC50, 800 µM) also in cellular antiviral assays."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T362","span":{"begin":0,"end":108},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Compound 29 was only weakly active against SARS‐CoV‐1 Mpro (IC50, 800 µM) also in cellular antiviral assays."}